These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

130 related articles for article (PubMed ID: 17922879)

  • 1. Survey of members of myeloma UK on biphosphonates-associated jaw osteonecrosis.
    Barker K; Lowe D; Olujohungbe A; Low E; Rogers SN
    Br J Haematol; 2007 Nov; 139(4):626-8. PubMed ID: 17922879
    [No Abstract]   [Full Text] [Related]  

  • 2. [The complications during the therapy for multiple myeloma].
    Spicka I
    Vnitr Lek; 2006 Feb; 52(2):115. PubMed ID: 16623271
    [No Abstract]   [Full Text] [Related]  

  • 3. [Avascular jaw osteonecrosis associated with bisphophonate therapy].
    Broglia C; Merlati G; Valentino F; Benatti C; Gobbi P; Ascari E
    Recenti Prog Med; 2006 Mar; 97(3):140-4. PubMed ID: 16700419
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Reduced serum levels of Interleukin 17 in patients with osteonecrosis of the jaw and in multiple myeloma subjects after bisphosphonates administration.
    Oteri G; Allegra A; Bellomo G; Alonci A; Nastro E; Penna G; Catalfamo L; Cicciù D; De Ponte FS; Musolino C
    Cytokine; 2008 Aug; 43(2):103-4. PubMed ID: 18585926
    [No Abstract]   [Full Text] [Related]  

  • 5. Multiple myeloma.
    Altundag K; Altundag O; Gundeslioglu O
    N Engl J Med; 2005 Feb; 352(8):840-1; author reply 840-1. PubMed ID: 15728824
    [No Abstract]   [Full Text] [Related]  

  • 6. Bisphosphonate-induced osteonecrosis of the jaw: long-term outcomes.
    Katz J; George T; Sandow P; Machado M; Dickerson L; Moreb JS
    J Support Oncol; 2009; 7(1):9-10. PubMed ID: 19278171
    [No Abstract]   [Full Text] [Related]  

  • 7. Osteonecrosis of the jaw and bisphosphonates.
    Durie BG; Katz M; Crowley J
    N Engl J Med; 2005 Jul; 353(1):99-102; discussion 99-102. PubMed ID: 16000365
    [No Abstract]   [Full Text] [Related]  

  • 8. [Osteonecrosis of the jaw in the course of multiple myeloma treatment and bisphosphonate administration].
    Adam Z; Kozumpliková M; Pour L; Machálka M
    Vnitr Lek; 2006 Feb; 52(2):176-80. PubMed ID: 16623282
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Osteonecrosis of the jaw associated with the use of bisphosphonates in multiple myeloma: report of four cases and literature review].
    Li LH; Wu XB; Chen WM; Chen JX; Wu Y; Chen SL
    Zhonghua Yi Xue Za Zhi; 2008 Nov; 88(42):2986-7. PubMed ID: 19080077
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Osteonecrosis associated with the use of biphosphonates: Case report].
    Anguita C T; Agurto P J; Roa E I; Laissle C G
    Rev Med Chil; 2006 Sep; 134(9):1161-5. PubMed ID: 17171218
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Osteonecrosis of the jaw associated with zoledronate therapy in a patient with multiple myeloma.
    Vannucchi AM; Ficarra G; Antonioli E; Bosi A
    Br J Haematol; 2005 Mar; 128(6):738. PubMed ID: 15755276
    [No Abstract]   [Full Text] [Related]  

  • 12. Osteonecrosis of the jaw and bisphosphonates.
    Maerevoet M; Martin C; Duck L
    N Engl J Med; 2005 Jul; 353(1):99-102; discussion 99-102. PubMed ID: 16003838
    [No Abstract]   [Full Text] [Related]  

  • 13. Bisphosphonates, osteonecrosis of the jaw, and dental treatment recommendations.
    Radfar L; Masood F
    J Okla Dent Assoc; 2008; 99(7):28-9. PubMed ID: 18595621
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Oral sodium clodronate induced osteonecrosis of the jaw in a patient with myeloma.
    Montazeri AH; Erskine JG; McQuaker IG
    Eur J Haematol; 2007 Jul; 79(1):69-71. PubMed ID: 17598839
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Bisphosphonate osteonecrosis of the jaws; an increasing problem for the dental practitioner.
    McLeod NM; Davies BJ; Brennan PA
    Br Dent J; 2007 Dec; 203(11):641-4. PubMed ID: 18065983
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The dilemma of jaw osteonecrosis in patients with multiple myeloma.
    Gertz MA; Koka S
    Leuk Lymphoma; 2008 Nov; 49(11):2037-9. PubMed ID: 19021045
    [No Abstract]   [Full Text] [Related]  

  • 17. Use of bisphosphonates in multiple myeloma: IMWG response to Mayo Clinic consensus statement.
    Durie BG
    Mayo Clin Proc; 2007 Apr; 82(4):516-7; author reply 517-8. PubMed ID: 17418085
    [No Abstract]   [Full Text] [Related]  

  • 18. I've heard that bisphosphonate medications used for osteoporosis can affect a person's jaw. Can you tell me more?
    Mayo Clin Womens Healthsource; 2008 Sep; 12(9):8. PubMed ID: 18667975
    [No Abstract]   [Full Text] [Related]  

  • 19. Bisphosphonate-related osteonecrosis: genetic and acquired risk factors.
    Sarasquete ME; González M; San Miguel JF; García-Sanz R
    Oral Dis; 2009 Sep; 15(6):382-7. PubMed ID: 19413677
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [New development in bisphosphonate treatment. Bisphosphonate therapy and osteonecrosis of the jaws].
    Urade M
    Clin Calcium; 2009 Jan; 19(1):100-8. PubMed ID: 19122270
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.